IMHO an equivalent ASX listed product / businesses include AVH & NAN;
AVH: Annual revenue = 100m, NP = 10m, Market cap = $2.13 Billion
NAN: Annual revenue run rate = 20 m, NP = nil, Market Cap = $778 million
GSS: Annual Revene run rate = 37m, NP = 10m whilst sustaining costs associated with growth of 500% P.A. plus, Market Cap = $283 million
Due to the net profit parity - albeit with faster growth & a larger addressable market, IMHO price target for the market cap is value parity with NAN $2.83 billion, circa $20 per share conservatively if growth slows to normal within 5 years, if growth continues at the current rate & due to the boost from relationships formed it could be much much earlier.
Hopefully the co - targets reimbursement lobbying for superior products across EU / ANZ as a priority, options and share incentives for high performing well connected health sales team or contractors and in fact blows my target price out of the water
IMHO an equivalent ASX listed product / businesses include AVH &...
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
80.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $181.2M | |||
| Open | High | Low | Value | Volume |
| 79.0¢ | 80.0¢ | 77.0¢ | $307.5K | 390.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | 78.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 80.0¢ | 296 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| GSS (ASX) Chart |